EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Relation between resting amygdala activity and cardiovascular events in patients with cardiac sarcoidosis

Sou Otsuki iD, Masahiro Hatakeyama, Atsushi Michael Kimura, Kosei Nakamura, Mikhail Ratanov, Rie Akagawa, Hironori Furuse, Naomasa Suzuki, Yasuhiro Ikami, Yuki Hasegawa, Masaomi Chinushi, Hitoshi Shimada und 1 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2025

DOI: 10.1007/s00259-025-07266-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2025. Verfasst von Sou Otsuki und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachidori, Chuo-ku, …. Hauptthemen laut MEDLINE: Sarcoidosis, Cardiomyopathies, Amygdala, Rest. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Previous studies indicate amygdala activity (AmygA) measured by FDG-positron emission tomography (PET) predicts the risk of subsequent cardiovascular events. However, AmygA measurement use for predicting the prognosis of patients with cardiac sarcoidosis (CS) is unknown. We aimed to investigate the association between AmygA and cardiovascular events in patients with CS.

Methods

Consecutive 40 patients with CS who underwent FDG-PET were identified retrospectively. Cardiovascular events included ventricular tachyarrhythmias and heart failure hospitalizations. We examined the association between AmygA and cardiovascular events and investigated the timing of FDG-PET influence on AmygA measurements.

Results

During a follow-up of 4.5 (2.5–7.7) years, 14 (35%) patients experienced cardiovascular events. Left-AmygA was a stronger cardiovascular event predictor than the Right-AmygA, and incidences were significantly higher in the high left-AmygA group than low group (log-rank P = 0.018). Multivariable analysis revealed left-AmygA augmentation (hazard ratio [HR]: 1.76 per 0.1 increase, 95% confidence interval [CI]: 1.12–2.87, P = 0.016) was the only independent predictor of cardiovascular event. Among the 40 patients, 32 underwent multiple PET-scans. No significant difference was found between the AmygA value on the first PET-scan and the mean on multiple PET scans, and the correlation coefficient was 0.93 ( P < 0.001). Multivariate analyses revealed the mean left-AmygA value was the only independent predictor of cardiovascular event ( P = 0.011).

Conclusions

High left-AmygA was associated with the higher rates of cardiovascular events in patients with CS. AmygA would be a prognostic biomarker regardless of the PET-scan timing.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcoidosisCardiomyopathiesAmygdalaRestHumansMaleFemaleMiddle AgedPositron-Emission TomographyFluorodeoxyglucose F18Retrospective StudiesAgedPrognosisAdult

Stichwörter der Autor:innen

18F-FDG-positron emission tomographyAmygdalaCardiac sarcoidosisStress-related neural activityVT/VF

Substanzen

Fluorodeoxyglucose F18

Autor:innen und Institutionen

  • Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachidori, Chuo-ku, Niigata, 951-8510, Japan. tallmoca_0825@yahoo.co.jp.
  • Department of Functional Neurology & Neurosurgery, Center for Integrated Human Brain Science, Brain Research Institute, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, 951-8510, Japan.
  • Department of Cardiovascular Biology and Medicine, Niigata University Graduate School of Medical and Dental Sciences, 1-757 Asahimachidori, Chuo-ku, Niigata, 951-8510, Japan.
  • Niigata University School of Medicine, Niigata, Japan.
  • Department of Functional Neurology & Neurosurgery, Center for Integrated Human Brain Science, Brain Research Institute, Niigata University, 1-757 Asahimachidori, Chuo-ku, Niigata, 951-8510, Japan. shimada.hitoshi@bri.ni…

ORCID-Profile: Sou Otsuki

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Otsuki, S., Hatakeyama, M., Kimura, A. M., Nakamura, K., Ratanov, M., Akagawa, R., Furuse, H., Suzuki, N., Ikami, Y., Hasegawa, Y., Chinushi, M., Shimada, H., & Inomata, T. (2025). Relation between resting amygdala activity and cardiovascular events in patients with cardiac sarcoidosis. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-025-07266-3

Vancouver

Otsuki S, Hatakeyama M, Kimura AM, Nakamura K, Ratanov M, Akagawa R, et al. Relation between resting amygdala activity and cardiovascular events in patients with cardiac sarcoidosis. European Journal of Nuclear Medicine and Molecular Imaging. 2025. doi:10.1007/s00259-025-07266-3

BibTeX
@article{Otsuki2025,
  author = {Otsuki, Sou and Hatakeyama, Masahiro and Kimura, Atsushi Michael and Nakamura, Kosei and Ratanov, Mikhail and Akagawa, Rie and Furuse, Hironori and Suzuki, Naomasa and Ikami, Yasuhiro and Hasegawa, Yuki and Chinushi, Masaomi and Shimada, Hitoshi and Inomata, Takayuki},
  title = {Relation between resting amygdala activity and cardiovascular events in patients with cardiac sarcoidosis},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2025},
  doi = {10.1007/s00259-025-07266-3}
}
Kostenlos starten →